Dharmesh Kharwar Joins ENTOD Pharmaceuticals As Independent Director

Mumbai-based ENTOD Pharmaceuticals has appointed Dharmesh Kharwar as a non-executive independent director on its board. With an impressive career trajectory, Kharwar has previously held significant positions at FDC , Johnson & Johnson (J&J), and MSD/Merck. He also currently serves on the boards of both listed and private companies, bringing a wealth of experience in development, manufacturing, regulatory affairs, quality assurance, business development, intellectual property protection, and commercial leadership across the chemical and biologics sectors.

Kharwar has a proven track record of driving innovation and growth, having successfully led large-scale projects, established international collaborations, and contributed to the advancement of both chemical and biological therapeutics. His deep understanding of regulatory frameworks and market strategies positions him as a valuable asset to ENTOD Pharmaceuticals.

Expressing his enthusiasm about the appointment, Kharwar stated, "I am honoured to join ENTOD Pharmaceuticals, a company that places a strong emphasis on being patient- and physician-centric. This focus has fueled its groundbreaking innovations for nearly five decades, and I am excited to contribute to its continued success."

ENTOD’s CEO, Nikkhil K Masurkar, expressed confidence in Kharwar’s capabilities: “I am confident that  Kharwar’s expertise and leadership will further strengthen our mission of delivering world-class, cost-effective pharmaceutical solutions and raising the bar for research and innovation.”

Founded 47 years ago, ENTOD Pharmaceuticals specialises in the research and development of products in the ENT, ophthalmology, and dermatology sectors, boasting an impressive portfolio of over 250 products across various R&D branches.